Tag Archive

Cancer Vaccine Market becomes more competitive A new report predicts the therapeutic vaccines segment of the immunotherapy market sales to reach $1.2 billion in 2020, however vaccine makers will have their fair share of hurdles over the next 6 years in order to make it there, as well as integrating into a challenging market first. The report comes from …

A team of academics lead by University of Maryland’s Christopher Jewell, professor of bioengineering, have been awarded a $375,000 grant this week to develop a vaccine to help combat neuroblastoma, the third most common pediatric cancer. The prototype vaccine tackles the cancer cells through stimulating the body’s own immune response. What Professor Jewel hopes will make this vaccine work more …